Abbott Still Worried About Alere Pact Even After SEC Filing
Abbott Laboratories still has concerns about its proposed $5.8 billion merger with Alere Inc., which belatedly filed its 2015 annual report on Monday after delays related to how it counted revenue...To view the full article, register now.
Already a subscriber? Click here to view full article